Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,665,463
+$42,189 QoQ
Shares Held
10,627
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#478
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOSTON FAMILY OFFICE LLC holds $74,645,423 across 10 Drug Manufacturers - General names. NVS ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,325 | $21,979,556 | |
| 2 | ABBV |
AbbVie Inc.
|
69,593 | $17,512,382 | |
| 3 | JNJ |
Johnson & Johnson
|
68,219 | $17,325,579 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,081 | $5,535,908 | |
| 5 | AMGN |
Amgen Inc
|
10,368 | $3,754,460 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
16,037 | $2,026,114 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,077 | $1,790,656 | |
| 8 | NVO |
Novo Nordisk A S
|
36,941 | $1,770,951 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,665,463 | 10,627 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,623,274 | 10,627 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,383,525 | 10,035 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,620,312 | 12,635 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,565,264 | 12,935 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,441,993 | 12,935 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,258,704 | 12,935 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,487,783 | 12,935 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,377,060 | 12,935 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,251,202 | 12,935 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,321,192 | 13,085 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,332,838 | 13,085 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,320,407 | 13,085 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,369,696 | 14,888 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,350,367 | 14,885 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,177,014 | 15,485 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,308,947 | 15,485 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,389,521 | 15,835 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,433,195 | 16,385 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,375,130 | 16,815 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,582,466 | 17,344 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,512,483 | 17,694 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $1,730,429 | 18,325 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,593,542 | 18,325 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,600,505 | 18,325 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,510,896 | 18,325 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||